TradeFlare's AI research teams analysed BIOA on 3 market nights between June 24, 2026 and July 28, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| July 28, 2026 | BUY | $20.88 | — / — | -48.9% | -53.9% | The current setup does not meet the criteria for a buy recommendation. |
| July 14, 2026 | BUY | $21.78 | — / — | -0.6% | -53.2% | Phase 2 study initiation and positive Phase 1 data for BGE-102. |
| June 24, 2026 | BUY | $22.32 | $30.00 / $18.97 | +6.3% | -4.1% | The post-earnings drift pattern suggests momentum could persist for several weeks. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.